Foresite Capital

Foresite Capital is a multi-stage investment firm specializing in healthcare and life sciences, managing $2 billion in assets. Established in 2011, the firm focuses on growth equity investments across various sectors, including pharmaceuticals, biotechnology, and healthcare technology. Foresite Capital employs a data-driven and scientific approach to its investment analysis, collaborating closely with portfolio companies through a multidisciplinary team of professionals, including scientists, engineers, analysts, and clinicians. This collaborative strategy aims to address significant unmet clinical needs by supporting promising businesses at different stages of their development. The firm places particular emphasis on companies that leverage data science and machine intelligence within the healthcare sector. Foresite Capital is headquartered in San Francisco, with an additional office in New York.

Vik Bajaj

Managing Director at Foresite Capital Management

Jacob Barlow

Senior Associate

Hyung Chun

Senior Director

Insiya Essani

Senior Associate

Chase Kelley

Senior Associate

Dorothy Margolskee

Managing Director

Hemaka Rajapakse

Senior Director

Jonathan Robbins

Director

Michael Rome

Managing Director

Austin Nalen Sprole

Senior Associate

Hadi Tabbaa

Managing Director

Jim Tananbaum

Founder and CEO

Tony Wiemelt

Director

Past deals in Series H

DNAnexus

Series H in 2022
DNAnexus, Inc. specializes in cloud-based genome informatics and data management tools tailored for enterprises and organizations involved in genomic medicine. Founded in 2009 and headquartered in Mountain View, California, the company provides a platform that facilitates the analysis of raw sequencing data, integrates genomic data with clinical information, and enhances collaboration among researchers. Key offerings include the MOSAIC Microbiome platform for microbiome research, DNAnexus Apollo for clinico-genomic data exploration, DNAnexus Titan for data analysis, and DNAnexus Portals, which create secure online workspaces for collaborative projects. Additionally, the Clinico-Genomic Data Solution aims to enhance disease-specific datasets through partnerships with healthcare providers, improving screening and treatment pathways for complex diseases. DNAnexus serves a diverse clientele, including biopharmaceutical companies, genome centers, and diagnostic test providers, and has established a strategic alliance with WuXi NextCODE Genomics. The company also maintains additional offices in San Francisco, London, and Prague.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.